Flagship's AI unicorn Generate raises $273M Series C, as first drug in 17-program pipeline enters the clinic - Endpoints News
endpts.comSubmitted by endpointsnews6292 in business
Flagship Pioneering’s AI-focused startup Generate:Biomedicines has raised another megaround that will push multiple drug programs into the clinic. The Somerville, MA-based biotech said Thursday it has closed a $273 million Series C round bringing in new inves…